← Open Payments lookup

CATHERINE BRAUN: Open Payments

NPI 1841597077 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$904 in 42 payments from 17 companies in 2025. Trend: 2023 $568 · 2024 $606 · 2025 $904

Food & beverage: $804Education: $100
CompanyPaymentsAmount
Astellas Pharma US Inc7$233
Sumitomo Pharma America, Inc.4$108
Novo Nordisk Inc5$81
PFIZER INC.4$77
GlaxoSmithKline, LLC.4$76
Amgen Inc.3$61
SANOFI PASTEUR INC.2$57
Lilly USA, LLC3$48
AstraZeneca Pharmaceuticals LP2$29
Exact Sciences Corporation1$24

Products named: Veozah, GEMTESA, EVENITY, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, MOUNJARO, PREVNAR 20, Ozempic, TRELEGY ELLIPTA.

Industry payments across TX — which companies pay providers there.